EFFECT OF VINCAMINE SUBSTANCE ON SPERMATOGENESIS WITH DIABETES
The present invention relates to the vincamine substance in certain doses for use in the prevention, relief of symptoms or treatment of disorders in the spermatogenesis process, changes in sperm count/motility and seminal fluid and decreases in testosterone levels observed in diabetic individuals..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 15. Juni Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
KÖPRÜLÜ RABIE EDIBE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-06-15, Last update posted on www.tib.eu: 2023-10-25, Last updated: 2023-11-03 |
|---|
| Patentnummer: |
WO2023107073 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017506336 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017506336 | ||
| 003 | DE-627 | ||
| 005 | 20231103091019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230708s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017506336 | ||
| 035 | |a (EPA)WO2023107073 | ||
| 035 | |a (EPA)85114251 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a KÖPRÜLÜ RABIE EDIBE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EFFECT OF VINCAMINE SUBSTANCE ON SPERMATOGENESIS WITH DIABETES |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-06-15, Last update posted on www.tib.eu: 2023-10-25, Last updated: 2023-11-03 | ||
| 520 | |a The present invention relates to the vincamine substance in certain doses for use in the prevention, relief of symptoms or treatment of disorders in the spermatogenesis process, changes in sperm count/motility and seminal fluid and decreases in testosterone levels observed in diabetic individuals. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a OKUR MEHMET EVREN |4 aut | |
| 700 | 0 | |a ÖZBEK HANEFI |4 aut | |
| 700 | 0 | |a KESKIN ILKNUR |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 15. Juni |
| 773 | 1 | 8 | |g year:2023 |g day:15 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/85114251/publication/WO2023107073A1?q=WO2023107073 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 15 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 15 |c 06 | ||